Cryoablation Immuno Therapy

Posted on June 9, 2015 by

Clinical Study Phase I Cryoimmunotherapy against Metastatic prostate Cancer Disease.


Dr. Israel Barken, the Medical Director of the Prostate Cancer Research and Education, presents a clinical study phase I, featuring cryosurgery plus immuno-Modulator – Cyclophosphamide and Anti CTLA 4 Antibodies- Ipilimumab (Yervoy)

This entry was posted in Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Prostate Cancer, Treatments for Prostate Cancer, Vaccine. Bookmark the permalink.